HER2, a HER2-targeted immunotherapy, with plans for FDA submission following promising Phase 2b data in osteosarcoma.

NEW YORK - OS Therapies, Inc. (NYSE-A: OSTX), a small-cap biotech firm with a market capitalization of $42 million focusing on cancer treatment solutions, has announced the completion of its Phase 2b ...

A new review was published in Oncotarget, Volume 16, on February 12, 2025, titled “SETDB1 amplification in osteosarcomas: ...

Davis Randle's teammates said the strength he's showed throughout the struggle of battling cancer has motivated them all season.

His story touched thousands when, in December last year, his dream of meeting actor Reynolds became a reality following an ...

Battling a rare form of cancer, Massi Agosti of Penn Valley found unwavering support from the Eagles and the player he loved ...

A Rockville immunotherapy company struck an $8 million deal to take back ownership of the drug candidates it’s been licensing ...

paving the way for groundbreaking work in osteosarcoma and expanding opportunities in lung and prostate cancer. I look forward to contributing to OS Therapies' mission of transforming cancer care ...

After finally getting a MRI scan in December 2023 the devastating diagnosis was revealed: osteosarcoma. Doctors informed her that amputation was the only way to prevent the cancer from spreading.

Osteosarcoma is the most common primary malignant bone tumor. Although surgery and chemoradiotherapy have made some progress in the treatment of osteosarcoma. However, the high recurrence and ...

The Trump administration abruptly cancelled NIH grant-review panel meetings, along with NIH travel and hiring, after all federal health officials were ordered to freeze public communications. The ...

A ketogenic diet may have health benefits for the treatment or prevention of cancer. But research is mixed, and it can have downsides for people receiving ongoing cancer treatment. Cancer is most ...